SCTX LLY scribe Therapeutics - IPO price expected between $13 and $15 per share - SEC filing Scribe Therapeutics - launches IPO of 7,150,000
SCTX LLY scribe Therapeutics - IPO price expected between $13 and $15 per share - SEC filing Scribe Therapeutics - launches IPO of 7,150,000 common shares - SEC filing - Aventis and genzyme to purchase $7.50M in shares via concurrent private placement - SEC filing Scribe Therapeutics Inc - Eli Lilly has indicated interest in purchasing Co's shares of common stock at IPO price
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.